Immune Memory After Papillomavirus Vaccination

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

quadrivalent HPV vaccine

For the group who have received two prior doses of vaccine, the third and final dose of vaccine will be given. For the unvaccinated cohort, women will receive all three doses of the vaccine. The second dose of the vaccine will be given two months after the first dose. The third and final dose of the vaccine will be given six months after the first dose.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER

NCT01505049 - Immune Memory After Papillomavirus Vaccination | Biotech Hunter | Biotech Hunter